TY  - JOUR
AU  - Fuentes-Fayos, Antonio C
AU  - G-Garcia, Miguel E
AU  - Perez-Gomez, Jesus M
AU  - Peel, Annabel
AU  - Blanco-Acevedo, Cristobal
AU  - Solivera, Juan
AU  - Ibañez-Costa, Alejandro
AU  - Gahete, Manuel D
AU  - Castaño, Justo P
AU  - Luque, Raul M
PY  - 2022
DO  - 10.3390/ijms23031143
UR  - http://hdl.handle.net/10668/21135
T2  - International journal of molecular sciences
AB  - Glioblastoma (GBM) is the most malignant and lethal brain tumor. Current standard treatment consists of surgery followed by radiotherapy/chemotherapy; however, this is only a palliative approach with a mean post-operative survival of scarcely ~12-15...
LA  - en
PB  - MDPI
KW  - Glioblastoma
KW  - Somatostatin analogs
KW  - Somatostatin receptor
KW  - Splicing variant
KW  - Sst5TMD4
KW  - Adult
KW  - Aged
KW  - Alternative splicing
KW  - Brain neoplasms
KW  - Cell line, tumor
KW  - Cell movement
KW  - Cell proliferation
KW  - Cell survival
KW  - Drug resistance, neoplasm
KW  - Female
KW  - Gene expression regulation, neoplastic
KW  - Glioblastoma
KW  - Humans
KW  - Male
KW  - Middle aged
KW  - Neoplasm recurrence, local
KW  - Prognosis
KW  - Receptors, somatostatin
KW  - Signal transduction
KW  - Somatostatin
KW  - Up-regulation
TI  - Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance.
TY  - research article
VL  - 23
ER  -